Explore recent issues of Contract Pharma covering key industry trends.
Read the full digital version of our magazine online.
Stay informed! Subscribe to Contract Pharma for industry news and analysis.
Get the latest updates and breaking news from the pharmaceutical and biopharmaceutical industry.
Discover the newest partnerships and collaborations within the pharma sector.
Keep track of key executive moves and promotions in the pharma and biopharma industry.
Updates on the latest clinical trials and regulatory filings.
Stay informed with the latest financial reports and updates in the pharma industry.
Expert Q&A sessions addressing crucial topics in the pharmaceutical and biopharmaceutical world.
In-depth articles and features covering critical industry developments.
Access exclusive industry insights, interviews, and in-depth analysis.
Insights and analysis from industry experts on current pharma issues.
A one-on-one video interview between our editorial teams and industry leaders.
Listen to expert discussions and interviews in pharma and biopharma.
A detailed look at the leading US players in the global pharmaceutical and BioPharmaceutical industry.
Browse companies involved in pharmaceutical manufacturing and services.
Comprehensive company profiles featuring overviews, key statistics, services, and contact details.
A comprehensive glossary of terms used in the pharmaceutical and biopharmaceutical industry.
Watch in-depth videos featuring industry insights and developments.
Download in-depth eBooks covering various aspects of the pharma industry.
Access detailed whitepapers offering analysis on industry topics.
View and download brochures from companies in the pharmaceutical sector.
Explore content sponsored by industry leaders, providing valuable insights.
Stay updated with the latest press releases from pharma and biopharma companies.
Explore top companies showcasing innovative pharma solutions.
Meet the leaders driving innovation and collaboration.
Engage with sessions and panels on pharma’s key trends.
Hear from experts shaping the pharmaceutical industry.
Join online webinars discussing critical industry topics and trends.
A comprehensive calendar of key industry events around the globe.
Live coverage and updates from major pharma and biopharma shows.
Find advertising opportunities to reach your target audience with Contract Pharma.
Review the editorial standards and guidelines for content published on our site.
Understand how Contract Pharma handles your personal data.
View the terms and conditions for using the Contract Pharma website.
What are you searching for?
Production is scheduled to begin in March 2022.
December 8, 2021
By: Charlie Sternberg
Biopharmaceutical fluid path component provider, BioPure, part of Watson-Marlow Fluid Technology Group (WMFTG), has received the keys for its custom-built facility at Dunsbury Park, with production due to begin in March 2022. Beginning construction in 2019, the new facility is five times the size of the company’s previous two buildings combined and will provide additional capacity to support the company’s ongoing growth and provide service to its customers. Comprising 120,000 sq. ft, this new facility will help to support BioPure’s ambitious vision, growth and commitment to supporting customers worldwide. The company’s key aims include simplifying production operations, lowering cGMP manufacturing costs and reducing process validation. The new facility, based just 4 miles from the current site in Portsmouth, is now home to BioPure’s current team of 232 employees and aims to bring on a diverse range of new talent in manufacturing, engineering, production, design, assembly, logistics and administration. The expansion will create 130 new jobs across a range of disciplines and the company is looking for talented individuals to join the team. To ensure customers receive products and services of the highest quality, the company will continue to use existing production equipment at the new site. There will be no change in raw materials, nor will there be any change in processing equipment or process methods. Revalidation of each molding machine and metrology comparison with products from the old manufacturing process has ensured that there is no change to the fit, form or function of BioPure’s products. Steve Feasey, manager director of BioPure, commented, “This is a very exciting time for BioPure, with demand for our products increasing year on year. We’re thrilled to get the keys to our new facility, providing increased capacity for us to deliver our high-quality fluid path components and strengthen our support for the pharmaceutical and biotechnology industry. This demonstrates our ongoing commitment to improving our customer service and our team is excited to start work from this state-of-the-art facility. We look forward to continuing to grow and develop more market-leading fluid management solutions.”
Enter your account email.
A verification code was sent to your email, Enter the 6-digit code sent to your mail.
Didn't get the code? Check your spam folder or resend code
Set a new password for signing in and accessing your data.
Your Password has been Updated !